Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR32 pseudogene 1 (GPR32P1) is a human pseudogene located on chromosome 19. It is designated as a "putative" G protein-coupled receptor based on sequence homology but is non-functional as it does not encode a complete, active protein[3][11][12]. Unlike the related gene GPR32, which encodes a functional G protein-coupled receptor involved in endogenous lipid mediator signaling, GPR32P1 is specified as a pseudogene, often lacking critical coding capacity or transmembrane domains necessary for receptor activity[12]. No disease associations, biomarker utility, interactions with drugs, or biological functions have been established for this pseudogene. Key clarification: - GPR32P1 is *not* the same as G protein-coupled receptor 32 (GPR32), which is a functional receptor involved in inflammation resolution signaling; GPR32P1 is an inactive pseudogene and is not a therapeutic target[3][12].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 32 pseudogene 1 (GPR32P1).